Suchergebnisse - "Zhu, Jin-Jin"

PubPharm (19)

1

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Annals of surgical oncology | 2023

von Zhu, X. | Huang, C. | Shen, Y. | +12

2

ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Annals of surgical oncology | 2023

von Zhu, X. | Huang, C. | Shen, Y. | +12

3

ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Annals of surgical oncology | 2023

von Zhu, X. | Huang, C. | Shen, Y. | +12

4

Peripheral naïve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma : a biomarker study

enthalten in: Cancer communications (London, England) | 2022

von Huang, C. | Xu, B. | Zhu, X. | +6

5

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Annals of surgical oncology | 2022

von Zhu, X. | Huang, C. | Shen, Y. | +12

6

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Annals of surgical oncology | 2022

von Zhu, X. | Huang, C. | Shen, Y. | +12

7

Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti-PD-1 antibody

enthalten in: Frontiers in immunology | 2022

von Xu, B. | Zhu, X. | Shen, Y. | +8

8

Peripheral naïve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma : a biomarker study

enthalten in: Cancer Communications | 2022

von Huang, C. | Xu, B. | Zhu, X. | +6

9

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

enthalten in: Liver cancer | 2021

von Zhu, X. | Huang, C. | Shen, Y. | +12

10

Neferine Protects against Hypoxic-Ischemic Brain Damage in Neonatal Rats by Suppressing NLRP3-Mediated Inflammasome Activation

enthalten in: Oxidative medicine and cellular longevity | 2021

von Zhu, J. | Yu, B. | Huang, X. | +9